| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
SUN 0237
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: ailanthone derivative; structure given in first source
Also Known As:11,20-epoxy-1,11,12-trihydroxy-15-(2-undecenoyl)oxypicras-3,13(21)-diene-2,16-dione; SUN-0237; SUN0237; Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-15-((1-oxo-2-undecenyl)oxy)-, (1beta,11beta,12alpha,15beta(E))-
Bio-Agent Context: Research Results
Related Diseases
| 1. | Leukemia P388
07/01/1988
- "inoculated P388 leukemia mice, daily treatment with SUN2071 and SUN0237 significantly increased the lifespan (increases in lifespan in excess of 100% were achieved)"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | SUN 2071
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |